SCHEMBL4194743

SCHEMBL4194743

CC(=COc1ccc(Oc2ccccc2)cc1)C(=O)OCCCOc1c(C)cc(-c2cc(C)c(OCCCOC(=O)C(C)=COc3ccc(Oc4ccccc4)cc3)c(C)c2)cc1C

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.37
PPARA Q07869 5/20 0.37
FFAR4 Q5NUL3 4/20 0.37
FFAR1 O14842 1/20 0.37
PPARD Q03181 4/20 0.36
PPARG P37231 3/20 0.36
SRD5A2 P31213 1/20 0.36
LTA4H P09960 2/20 0.35
CYP3A4 P08684 1/20 0.35
KCNH2 Q12809 1/20 0.35
CACNA1C Q13936 1/20 0.35
SCN5A Q14524 1/20 0.35
NPC1 O15118 1/20 0.35
HPGD P15428 1/20 0.35
CRHBP P24387 1/20 0.35
RAB9A P51151 1/20 0.35
CRHR2 Q13324 1/20 0.35
ALDH1A1 P00352 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4198617 0.96 MEN1 (0.37) KDM4EPPARAFFAR4PPARDPPARG
SCHEMBL4197215 0.92 PPARG (0.43) PPARAFFAR4FFAR1PPARDPPARG
SCHEMBL4202675 0.88 FFAR4 (0.39) PPARAFFAR4FFAR1PPARDPPARG
SCHEMBL4198640 0.87 PPARG (0.47) PPARAFFAR4FFAR1PPARDPPARG
SCHEMBL4198605 0.87 KDM4E (0.36) KDM4EPPARAFFAR4PPARDPPARG
SCHEMBL4199991 0.85 FFAR4 (0.48) PPARAFFAR4FFAR1PPARDPPARG
SCHEMBL4190846 0.82 KDM4E (0.40) KDM4EALDH1A1SMN1; SMN2
SCHEMBL4197206 0.81 HDAC1 (0.46) PPARAFFAR4FFAR1PPARDPPARG
SCHEMBL4184738 0.80 PPARD (0.46) KDM4EPPARAFFAR4FFAR1PPARD
SCHEMBL4188598 0.79 HDAC1 (0.49) PPARAPPARDPPARGLTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1627867-B1 (METH)ACRYLIC ESTER COMPOUND AND USE THEREOF MITSUI CHEMICALS INC (JP) 2016-01-20 EP disclosed
US-7534909-B2 (Meth) acrylic ester compound and use thereof MITSUI CHEMICALS, INC. (JP) 2009-05-19 US disclosed
US-20070078198-A1 (Meth) acrylic ester compound and use thereof MITSUI CHEMICALS, INC. (JP) 2007-04-05 US disclosed
EP-1627867-A1 (METH)ACRYLIC ESTER COMPOUND AND USE THEREOF Mitsui Chemicals, Inc. (JP) 2006-02-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070078198-A1 (Meth) acrylic ester compound and use thereof METTL14, PAM, TAS2R41 KDM4E 270/4885PPARA 3322/4885FFAR4 1889/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.